Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTC-guided cisplatin in pretreated metastatic breast cancer
2012-005395-34Phase 2Completed
- Sponsor
- Erasmus MC
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cisplatin in breast cancer (3 arms), sponsored by Erasmus MC. Primary endpoint: Response rate after 4 cycles. Started Jan 2013; status: completed.
02
Drugs
cisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-005395-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005395-34.